Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Accuray Inc (ARAY)

Accuray Inc (ARAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 62,515
  • Shares Outstanding, K 118,783
  • Annual Sales, $ 458,510 K
  • Annual Income, $ -1,590 K
  • EBIT $ -18 M
  • EBITDA $ -10 M
  • 60-Month Beta 1.19
  • Price/Sales 0.14
  • Price/Cash Flow 12.37
  • Price/Book 1.23
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.30
  • Most Recent Earnings $-0.18 on 11/05/25
  • Next Earnings Date 04/29/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Instruments

Options Overview Details

View History
  • Implied Volatility 244.45% (-0.40%)
  • Historical Volatility 87.83%
  • IV Percentile 60%
  • IV Rank 30.27%
  • IV High 669.47% on 06/23/25
  • IV Low 59.94% on 11/17/25
  • Expected Move (DTE 15) 0.1275 (24.39%)
  • Put/Call Vol Ratio 0.06
  • Today's Volume 159
  • Volume Avg (30-Day) 163
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 21,471
  • Open Int (30-Day) 21,015
  • Expected Range 0.3953 to 0.6503

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.02
  • Growth Rate Est. (year over year) +4,994,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4900 +6.69%
on 03/03/26
0.6727 -22.28%
on 02/05/26
-0.2338 (-30.90%)
since 02/04/26
3-Month
0.4900 +6.69%
on 03/03/26
1.1300 -53.73%
on 12/11/25
-0.4972 (-48.75%)
since 12/04/25
52-Week
0.4900 +6.69%
on 03/03/26
2.1000 -75.10%
on 10/10/25
-1.3272 (-71.74%)
since 03/04/25

Most Recent Stories

More News
Accuray: Fiscal Q2 Earnings Snapshot

Accuray: Fiscal Q2 Earnings Snapshot

ARAY : 0.5228 (-0.67%)
Accuray Reports Fiscal 2026 Second Quarter Financial Results

MADISON, Wis. , Feb. 4, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2025.

ARAY : 0.5228 (-0.67%)
Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026

MADISON, Wis. , Jan. 21, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2026, ended December 31, 2025, during a conference...

ARAY : 0.5228 (-0.67%)
Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth

MADISON, Wis. , Dec. 15, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced the first phase of its comprehensive strategic, operational, and organizational transformation plan....

ARAY : 0.5228 (-0.67%)
Accuray: Fiscal Q1 Earnings Snapshot

Accuray: Fiscal Q1 Earnings Snapshot

ARAY : 0.5228 (-0.67%)
Accuray Reports Fiscal 2026 First Quarter Financial Results

MADISON, Wis. , Nov. 5, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2025.

ARAY : 0.5228 (-0.67%)
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules

MADISON, Wis. , Oct. 31, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Stephen La Neve, the company's new...

ARAY : 0.5228 (-0.67%)
Accuray to Report First Quarter Fiscal 2026 Financial Results on November 5, 2025

MADISON, Wis. , Oct. 28, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2026, ended September 30, 2025, during a conference...

ARAY : 0.5228 (-0.67%)
Accuray Accelerates Transformation Efforts with Appointment of Experienced Executive Leaders to Drive Performance and Growth

Industry Veteran Steve La Neve Named Chief Executive Officer  Suzanne Winter to Retire as President and CEO Company Appoints Steven F. Mayer as Transformation Board Sponsor...

ARAY : 0.5228 (-0.67%)
Biomarker-Driven Therapies And AI Technologies Transform $312B Precision Oncology Market

Issued on behalf of GT Biopharma, Inc. VANCOUVER – Baystreet.ca News Commentary – Biomarker-driven approaches enhance the likelihood of identifying optimal patient populations and streamline...

CORT : 35.69 (+1.16%)
ARAY : 0.5228 (-0.67%)
KURA : 8.55 (+0.59%)
GTBP : 0.4545 (-3.28%)
TNGX : 12.35 (+7.39%)

Business Summary

Accuray Inc. designs, develops & sells radiosurgery and radiation therapy systems for treatment of tumors in the body. The company's product suite includes the CyberKnife Systems and the TomoTherapy Systems. It primarily generates revenues by selling the CyberKnife & TomoTherapy Systems and providing...

See More

Key Turning Points

3rd Resistance Point 0.5534
2nd Resistance Point 0.5422
1st Resistance Point 0.5325
Last Price 0.5228
1st Support Level 0.5116
2nd Support Level 0.5004
3rd Support Level 0.4907

See More

52-Week High 2.1000
Fibonacci 61.8% 1.4850
Fibonacci 50% 1.2950
Fibonacci 38.2% 1.1050
Last Price 0.5228
52-Week Low 0.4900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar